Trump's New Deal: Affordable Obesity Drugs for All

President Trump unveils new deal to make obesity drugs more affordable, aiming to improve health of millions. Medicare patients to gain coverage next year, with lower prices for uninsured individuals. Deal targets GLP-one receptor agonists like Zepbound and Wegovy, effective for weight loss but previously costly. Administrations broader effort to control rising drug prices and address cost-of-living concerns. The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.